Skip to content
2000
Volume 21, Issue 2
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Introduction

Dihydropyridine-calcium channel blockers (DHP-CCBs) are effective first-line blood pressure-lowering agents for primary hypertension. However, data comparing the variations in efficacy and safety between different types of DHP-CCBs are scarce.

Aims and Objectives

This study aimed to summarize the latest evidence on the benefits and harms of seven DHP-CCBs (amlodipine, levamlodipine, felodipine, lacidipine, nitrendipine, nifedipine, and benidipine).

Methods

A meta-analysis of DHP-CCBs was carried out to explore differences in efficacy and safety. We searched PubMed, Embase, the Cochrane Library, CNKI, Wanfang Data, and VIP databases from inception to September, 2023, for randomized controlled trials (RCTs) comparing DHP-CCBs. The main outcomes were blood pressure lowering and adverse events (AEs) during treatment.

Results

We included 181 RCTs (21,383 patients) in this analysis. In terms of efficacy, levamlodipine ranked highest in reducing office blood pressure (surface under the cumulative ranking systolic blood pressure = 80.81%, diastolic blood pressure (DBP) = 82.42%) and 24-h ambulatory DBP (98.07%). Felodipine had the highest probability of reducing 24-h ambulatory blood pressure (80.65%). Regarding safety, levamlodipine had the least impact on heart rate (85.71%). In terms of AEs, benidipine had the highest rate for cardiovascular (86.58%) and digestive system (93.57%) AEs. Nifedipine and amlodipine had the highest rates of central (80.65%) and peripheral nervous system (83.28%) AEs, respectively. Levamlodipine exhibited significantly lower rates of total AEs (1.24%), central nervous system AEs (1.28%), and cardiovascular system AEs (3.62%) than the other interventions.

Conclusion

In the office setting, levamlodipine may be the best treatment for primary hypertension, and lacidipine shows good safety.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021357729250214090452
2025-02-24
2025-09-25

  • From This Site

    /content/journals/chyr/10.2174/0115734021357729250214090452
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZhouB. Carrillo-LarcoR.M. DanaeiG. RileyL.M. PaciorekC.J. StevensG.A. GreggE.W. BennettJ.E. SolomonB. SingletonR.K. SophieaM.K. IurilliM.L.C. LhosteV.P.F. CowanM.J. SavinS. WoodwardM. BalanovaY. CifkovaR. DamascenoA. ElliottP. FarzadfarF. HeJ. IkedaN. KengneA.P. KhangY-H. KimH.C. LaxmaiahA. LinH-H. Margozzini MairaP. MirandaJ.J. NeuhauserH. SundströmJ. VargheseC. WidyaheningI.S. ZdrojewskiT. Abarca-GómezL. AbdeenZ.A. Abdul RahimH.F. Abu-RmeilehN.M. Acosta-CazaresB. AdamsR.J. AekplakornW. AfsanaK. AfzalS. AgdeppaI.A. Aghazadeh-AttariJ. Aguilar-SalinasC.A. AgyemangC. AhmadN.A. AhmadiA. AhmadiN. AhmadiN. AhmadizarF. AhmedS.H. AhrensW. AjlouniK. Al-RaddadiR. AlaroujM. AlBuhairanF. AlDhukairS. AliM.M. AlkandariA. AlkerwiA. AllinK. AlyE. AmarapurkarD.N. AmougouN. AmouyelP. AndersenL.B. AnderssenS.A. AnjanaR.M. Ansari-MoghaddamA. AnsongD. Aounallah-SkhiriH. AraújoJ. AriansenI. ArisT. ArkuR.E. ArlappaN. AryalK.K. AspelundT. AssahF.K. AssunçãoM.C.F. AuvinenJ. AvdićováM. AzevedoA. Azimi-NezhadM. AziziF. AzminM. BabuB.V. BahijriS. BalakrishnaN. BamoshmooshM. BanachM. BanadinovićM. BandoszP. BanegasJ.R. BaranJ. BarbagalloC.M. BarcelóA. BarkatA. BarretoM. BarrosA.J.D. BarrosM.V.G. BartosiewiczA. BasitA. BastosJ.L.D. BataI. BatiehaA.M. BatyrbekA. BaurL.A. BeagleholeR. BelavendraA. Ben RomdhaneH. BenetM. BensonL.S. BerkinbayevS. Bernabe-OrtizA. BernotieneG. BettiolH. BezerraJ. BhagyalaxmiA. BhargavaS.K. BiaD. BiaschK. Bika LeleE.C. BikbovM.M. BistaB. BjerregaardP. BjertnessE. BjertnessM.B. BjörkelundC. BlochK.V. BlokstraA. BoS. BobakM. BoeingH. BoggiaJ.G. BoissonnetC.P. BojesenS.E. BongardV. Bonilla-VargasA. BoppM. BorghsH. BovetP. BoyerC.B. BraeckmanL. BrajkovichI. BrancaF. BreckenkampJ. BrennerH. BrewsterL.M. BriceñoY. BritoM. BrunoG. Bueno-de-MesquitaH.B. BuenoG. BuggeA. BurnsC. BursztynM. Cabrera de LeónA. CacciottoloJ. CameronC. CanG. CândidoA.P.C. CapanzanaM.V. ČapkováN. CapuanoE. CapuanoV. CardosoV.C. CarlssonA.C. CarvalhoJ. CasanuevaF.F. CensiL. Cervantes-LoaizaM. ChadjigeorgiouC.A. ChamukuttanS. ChanA.W. ChanQ. ChaturvediH.K. ChaturvediN. CheeM.L. ChenC-J. ChenF. ChenH. ChenS. ChenZ. ChengC-Y. CheraghianB. Cherkaoui DekkakiI. ChetritA. ChienK-L. ChioleroA. ChiouS-T. Chirita-EmandiA. ChirlaqueM-D. ChoB. ChristensenK. ChristofaroD.G. ChudekJ. CintezaE. ClaessensF. ClarkeJ. ClaysE. CohenE. ConcinH. CooperC. CoppingerT.C. CostanzoS. CottelD. CowellC. CraigC.L. CrampinA.C. CrujeirasA.B. CruzJ.J. CsillaS. CuiL. CureauF.V. CuschieriS. D’ArrigoG. d’OrsiE. DallongevilleJ. DanknerR. DantoftT.M. DauchetL. DavletovK. De BackerG. De BacquerD. De CurtisA. de GaetanoG. De HenauwS. de OliveiraP.D. De RidderD. De SmedtD. DeepaM. DeevA.D. DeGennaroV.J. DelisleH. DemarestS. DennisonE. DeschampsV. DhimalM. Di CastelnuovoA.F. Dias-da-CostaJ.S. DiazA. DickersonT.T. DikaZ. DjalaliniaS. DoH.T.P. DobsonA.J. DonfrancescoC. DonosoS.P. DöringA. DorobantuM. DörrM. DouaK. DraganoN. DrygasW. DuanteC.A. DubozP. DudaR.B. DulskieneV. DushpanovaA. DžakulaA. DzerveV. Dziankowska-ZaborszczykE. EddieR. EftekharE. EggertsenR. EghtesadS. EibenG. EkelundU. El-KhateebM. El AtiJ. Eldemire-ShearerD. EliasenM. ElosuaR. ErasmusR.T. ErbelR. EremC. EriksenL. ErikssonJ.G. Escobedo-de la PeñaJ. EslamiS. EsmaeiliA. EvansA. FaehD. FakhretdinovaA.A. FallC.H. FaramarziE. FarjamM. FattahiM.R. FawwadA. Felix-RedondoF.J. FelixS.B. FergusonT.S. FernandesR.A. Fernández-BergésD. FerranteD. FerraoT. FerrariM. FerrarioM.M. FerreccioC. FerreiraH.S. FerrerE. FerrieresJ. FigueiróT.H. FinkG. FischerK. FooL.H. ForsnerM. FouadH.M. FrancisD.K. FrancoM.C. Frikke-SchmidtR. FronteraG. FuchsF.D. FuchsS.C. FujitaY. FumihikoM. FurdelaV. FurerA. FurusawaT. GaciongZ. GalbarczykA. GalenkampH. GalvanoF. GaoJ. GaoP. Garcia-de-la-HeraM. GarciaP. GaretaD. GarnettS.P. GaspozJ-M. GasullM. GazzinelliA. GehringU. GeleijnseJ.M. GeorgeR. GhanbariA. GhasemiE. Gheorghe-FroneaO-F. GhimireA. GialluisiA. GiampaoliS. GiegerC. GillT.K. GiovannelliJ. GironellaG. GiwercmanA. GkiourasK. GoldbergM. GoldsmithR.A. GomezL.F. GomulaA. GonçalvesH. GonçalvesM. Gonçalves Cordeiro da SilvaB. Gonzalez-ChicaD.A. Gonzalez-GrossM. González-RivasJ.P. González-VillalpandoC. González-VillalpandoM-E. GonzalezA.R. GorbeaM.B. GottrandF. Graff-IversenS. GrafnetterD. GrajdaA. GrammatikopoulouM.G. GregorR.D. GrodzickiT. GrossoG. GrudenG. GuD. GuanO.P. GudmundssonE.F. GudnasonV. GuerreroR. GuessousI. GuimaraesA.L. GullifordM.C. GunnlaugsdottirJ. GunterM.J. GuptaP.C. GuptaR. GurejeO. GurzkowskaB. GutierrezL. GutzwillerF. HaS. HadaeghF. HaghshenasR. HakimiH. HalkjærJ. HambletonI.R. HamzehB. HangeD. HanifA.A.M. HantunenS. HaoJ. HardmanC.M. Hari KumarR. Hashemi-ShahriS.M. HataJ. HaugsgjerdT. HayesA.J. HeY. HeierM. HendriksM.E. HenriqueR.S. HenriquesA. Hernandez CadenaL. Herqutanto HerralaS. HeshmatR. HillA.G. HoS.Y. HoS.C. HobbsM. HoldsworthM. HomayounfarR. Horasan DincG. HorimotoA.R.V.R. HormigaC.M. HortaB.L. HoutiL. HowittC. HtayT.T. HtetA.S. HtikeM.M.T. HuY. HuertaJ.M. HuhtaniemiI.T. HuiartL. HuismanM. HusseiniA.S. HuybrechtsI. HwallaN. IacovielloL. IannoneA.G. IbrahimM.M. Ibrahim WongN. IkramM.A. IotovaV. IrazolaV.E. IshidaT. IsiguzoG.C. IslamM. IslamS.M.S. IwasakiM. JacksonR.T. JacobsJ.M. JaddouH.Y. JafarT. JamesK. JamrozikK. JanszkyI. JanusE. JarvelinM-R. JasienskaG. JelakovićA. JelakovićB. JenningsG. JhaA.K. JiangC.Q. JimenezR.O. JöckelK-H. JoffresM. JohanssonM. JokelainenJ.J. JonasJ.B. JørgensenT. JoshiP. JoukarF. JóżwiakJ. JuoleviA. JurakG. JurešaV. KaaksR. KafatosA. KajantieE.O. KalmatayevaZ. KalpourtziN. Kalter-LeiboviciO. KampmannF.B. KannanS. KaraglaniE. KårhusL.L. KarkiK.B. KatibehM. KatzJ. KauhanenJ. KaurP. KavousiM. KazakbaevaG.M. KeilU. Keinan BokerL. Keinänen-KiukaanniemiS. KelishadiR. KemperH.C.G. KeramatiM. KerimkulovaA. KerstingM. KeyT. KhaderY.S. KhaliliD. KhawK-T. KheiriB. KheradmandM. KhosraviA. Kiechl-KohlendorferU. KiechlS. KillewoJ. KimD.W. KimJ. KlakkH. KlimekM. KlumbieneJ. KnoflachM. KolleE. KolsterenP. KonttoJ.P. KorpelainenR. KorrovitsP. KosJ. KoskinenS. KoudaK. KowlessurS. KozielS. KratenovaJ. KriaucionieneV. KristensenP.L. KrokstadS. KromhoutD. KrugerH.S. KubinovaR. KucieneR. KujalaU.M. KulagaZ. KumarR.K. KurjataP. KusumaY.S. KutsenkoV. KuulasmaaK. KyobutungiC. LaatikainenT. LachatC. LaidY. LamT.H. LandroveO. LanskaV. LappasG. LarijaniB. LattT.S. Le CorollerG. Le Nguyen BaoK. LeT.D. LeeJ. LeeJ. LehmannN. LehtimäkiT. LemogoumD. LevittN.S. LiY. LillyC.L. LimW-Y. Lima-CostaM.F. LinX. LinY-T. LindL. LingamV. LinnebergA. LissnerL. LitwinM. LoW-C. LoitH-M. Lopez-GarciaE. LopezT. LotufoP.A. LozanoJ.E. Lukačević LovrenčićI. LukrafkaJ.L. LuksieneD. LundqvistA. LundqvistR. LunetN. LustigováM. LuszczkiE. MaG. MaJ. Machado-CoelhoG.L.L. Machado-RodriguesA.M. MaciaE. MacieiraL.M. MadarA.A. MaggiS. MaglianoD.J. MagriplisE. MahasampathG. MaireB. MajerM. MakdisseM. MalekzadehF. MalekzadehR. MalhotraR. Mallikharjuna RaoK. MalyutinaS.K. ManiegoL.V. ManiosY. MannJ.I. Mansour-GhanaeiF. ManzatoE. MarcilA. MårildS.B. Marinović GlavićM. Marques-VidalP. MarquesL.P. MarrugatJ. MartorellR. MascarenhasL.P. MatasinM. MathiesenE.B. MathurP. MatijasevichA. MatloszP. MatshaT.E. MavrogianniC. MbanyaJ.C.N. Mc Donald PossoA.J. McFarlaneS.R. McGarveyS.T. McLachlanS. McLeanR.M. McLeanS.B. McNultyB.A. Mediene BenchekorS. MedzionieneJ. MehdipourP. MehligK. MehrparvarA.H. MeirhaegheA. MeisingerC. Mendoza MontanoC. MenezesA.M.B. MenonG.R. MerekeA. MeshramI.I. MetspaluA. MeyerH.E. MiJ. MichelsN. MikkelK. MilkowskaK. MillerJ.C. MindericoC.S. MiniG.K. MirjaliliM.R. MirrakhimovE. Mišigoj-DurakovićM. ModestiP.A. MoghaddamS.S. MohajerB. MohamedM.K. MohamedS.F. MohammadK. MohammadiM.R. MohammadiZ. MohammadifardN. MohammadpourhodkiR. MohanV. MohannaS. Mohd YusoffM.F. MohebbiI. MohebiF. MoitryM. MøllehaveL.T. MolnárD. MomenanA. MondoC.K. Monterrubio-FloresE. MonyekiK.D.K. MoonJ.S. MoosazadehM. MoreiraL.B. MorejonA. MorenoL.A. MorganK. MoschonisG. MossakowskaM. MostafaA. MostafaviS-A. MotaJ. MotlaghM.E. MottaJ. Moura-dos-SantosM.A. MridhaM.K. MsyambozaK.P. MuT.T. MuhihiA.J. MuiesanM.L. Müller-NurasyidM. MurphyN. MursuJ. MusaK.I. Musić MilanovićS. MusilV. MustafaN. NabipourI. NaderimaghamS. NagelG. NaiduB.M. NajafiF. NakamuraH. NámešnáJ. NangE.E.K. NangiaV.B. NarakeS. NdiayeN.C. NealW.A. NejatizadehA. NenkoI. NeoviusM. NguyenC.T. NguyenN.D. NguyenQ.V. NguyenQ.N. Nieto-MartínezR.E. NiiranenT.J. NikitinY.P. NinomiyaT. NishtarS. NjelekelaM.A. NoaleM. NoboaO.A. NoorbalaA.A. NoratT. NordendahlM. NordestgaardB.G. NotoD. Nowak-SzczepanskaN. NsourM.A. NunesB. O’NeillT.W. O’ReillyD. OchimanaC. OdaE. OdiliA.N. OhK. OharaK. OhtsukaR. OliéV. OlintoM.T.A. OliveiraI.O. OmarM.A. OnatA. OngS.K. OnoL.M. OrdunezP. OrnelasR. OrtizP.J. OsmondC. OstojicS.M. OstovarA. OteroJ.A. OvervadK. Owusu-DaboE. PaccaudF.M. PadezC. PahomovaE. PaivaK.M. PająkA. PalliD. PalmieriL. PanW-H. Panda-JonasS. PanzaF. PaoliM. PapandreouD. ParkS-W. ParkS. ParnellW.R. ParsaeianM. PasquetP. PatelN.D. PavlyshynH. PećinI. PednekarM.S. PedroJ.M. PeerN. PeixotoS.V. PeltonenM. PereiraA.C. PeresK.G.D.A. PeresM.A. PetersA. PetkevicieneJ. PeykariN. PhamS.T. PichardoR.N. PigeotI. PikhartH. PilavA. PilottoL. PitakakaF. PiwonskaA. PizarroA. Plans-RubióP. PolašekO. PortaM. PoudyalA. PourfarziF. PourshamsA. PoustchiH. PradeepaR. PriceA.J. PriceJ.F. ProvidenciaR. PuhakkaS.E. PuiuM. PunabM. QasrawiR.F. QorbaniM. QueirozD. Quoc BaoT. RadićI. RadisauskasR. RahimikazerooniS. RahmanM. RaitakariO. RajM. RakhimovaE.M. Ramachandra RaoS. RamachandranA. RamosE. RampalL. RampalS. Rangel ReinaD.A. RarraV. RechC.R. RedonJ. ReganitP.F.M. RegecováV. RevillaL. RezaianzadehA. RibeiroR. RiboliE. RichterA. RigoF. Rinke de WitT.F. Ritti-DiasR.M. RobitailleC. Rodríguez-ArtalejoF. Rodriguez-PerezM.C. Rodríguez-VillamizarL.A. RoggenbuckU. Rojas-MartinezR. RomagueraD. RomeoE.L. RosengrenA. RoyJ.G.R. RubinsteinA. RuidavetsJ-B. Ruiz-BetancourtB.S. Ruiz-CastellM. RusakovaI.A. RussoP. RutkowskiM. SabanayagamC. SabbaghiH. SachdevH.S. SadjadiA. SafarpourA.R. SafiS. SafiriS. SaidiO. SakaryaS. SakiN. SalanaveB. Salazar MartinezE. SalmerónD. SalomaaV. SalonenJ.T. SalvettiM. Sánchez-AbantoJ. SansS. SantosD.A. SantosI.S. SantosL.C. SantosM.P. SantosR. SaramiesJ.L. SardinhaL.B. SarganasG. SarrafzadeganN. SathishT. SaumK-U. SavvaS. SawadaN. SbarainiM. ScazufcaM. SchaanB.D. SchargrodskyH. SchipfS. SchmidtC.O. SchnohrP. SchöttkerB. SchrammS. SchultszC. SchutteA.E. SebertS. SeinA.A. SenA. SenbanjoI.O. SepanlouS.G. ServaisJ. ShalnovaS.A. Shamah-LevyT. ShamshirgaranM. ShanthiraniC.S. SharafkhahM. SharmaS.K. ShawJ.E. ShayanradA. ShayestehA.A. ShiZ. ShibuyaK. Shimizu-FurusawaH. ShinD.W. ShiraniM. ShiriR. ShresthaN. Si-RamleeK. SianiA. SiantarR. SibaiA.M. SilvaC.R.M. SilvaD.A.S. SimonM. SimonsJ. SimonsL.A. SjöströmM. Slowikowska-HilczerJ. SlusarczykP. SmeethL. SoH-K. SoaresF.C. SobngwiE. SöderbergS. SoemantriA. SofatR. SolfrizziV. SomiM.H. SonestedtE. SongY. SørensenT.I.A. SørgjerdE.P. SorićM. Sossa JéromeC. SoumaréA. Sparboe-NilsenB. SparrenbergerK. StaessenJ.A. StarcG. StavreskiB. Steene-JohannessenJ. StehleP. SteinA.D. StergiouG.S. StessmanJ. StieberJ. StöcklD. StocksT. StokwiszewskiJ. StronksK. StrufaldiM.W. SukaM. SunC-A. SungY-T. SuriyawongpaisalP. SyR.G. SyddallH.E. SylvaR.C. SzkloM. TaiE.S. TammesooM-L. TamosiunasA. TanE.J. TangX. TanserF. TaoY. TarawnehM.R. Tarqui-MamaniC.B. TaylorA. TaylorJ. TebarW.R. TellG.S. TelloT. ThamY.C. ThankappanK.R. TheobaldH. TheodoridisX. ThijsL. ThinggaardM. ThomasN. ThorandB. ThuesenB.H. TimmermansE.J. TjandrariniD.H. TjonnelandA. ToftU. TolonenH.K. TolstrupJ.S. TopbasM. Topór-MadryR. TormoM.J. TornaritisM.J. TorrentM. Torres-ColladoL. TouloumiG. TraissacP. TriantafyllouA. TrichopoulosD. TrichopoulouA. TrinhO.T.H. TrivediA. TshepoL. TsuganeS. TuliakovaA.M. Tulloch-ReidM.K. TulluF. TuomainenT-P. TuomilehtoJ. TurleyM.L. TwigG. TyneliusP. TzourioC. UedaP. UgelE. UlmerH. UusitaloH.M.T. ValdiviaG. ValviD. van DamR.M. van den BornB-J. Van der HeydenJ. van der SchouwY.T. Van HerckK. Van MinhH. Van SchoorN.M. van ValkengoedI.G.M. van ZutphenE.M. VanderschuerenD. VanuzzoD. VarboA. VasanS.K. VegaT. VeidebaumT. Velasquez-MelendezG. VeronesiG. VerschurenW.M.M. VerstraetenR. VictoraC.G. VietL. VillalpandoS. VineisP. VioqueJ. VirtanenJ.K. Visvikis-SiestS. ViswanathanB. VlasoffT. VollenweiderP. VoutilainenA. WadeA.N. WaltonJ. WambiyaE.O.A. Wan BebakarW.M. Wan MohamudW.N. Wanderley JúniorR.S. WangM-D. WangN. WangQ. WangX. WangY.X. WangY-W. WannametheeS.G. WarehamN. WeiW. WeresA. WernerB. WhincupP.H. WidhalmK. WiecekA. WilksR.J. WilleitJ. WilleitP. WilliamsE.A. WilsgaardT. WojtyniakB. Wong-McClureR.A. WongA. WongT.Y. WooJ. WuF.C. WuS. WyszynskaJ. XuH. XuL. YaacobN.A. YanW. YangL. YangX. YangY. YasuharuT. YeX. YiallourosP.K. YoosefiM. YoshiharaA. YouS-L. Younger-ColemanN.O. YusoffA.F. ZainuddinA.A. ZakaviS.R. ZamaniF. ZambonS. ZampelasA. ZapataM.E. ZawK.K. ZejglicovaK. Zeljkovic VrkicT. ZengY. ZhangL. ZhangZ-Y. ZhaoD. ZhaoM-H. ZhenS. ZhengY. ZholdinB. ZhuD. ZinsM. ZittE. ZocaloY. ZoghlamiN. Zuñiga CisnerosJ. EzzatiM. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants.Lancet20213981030495798010.1016/S0140‑6736(21)01330‑134450083
     [Google Scholar]
  2. Writing Group of 2018 Chinese Guidelines for the Management of Hypertension. [2018 Chinese guidelines for the management of hypertension].Chin J Cardiovasc Med2019242456
     [Google Scholar]
  3. WangJ.G. KarioK. LauT. WeiY.Q. ParkC.G. KimC.H. HuangJ. ZhangW. LiY. YanP. HuD. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association.Hypertens. Res.201134442343010.1038/hr.2010.25921228778
     [Google Scholar]
  4. LeenenF.H.H. NwachukuC.E. BlackH.R. CushmanW.C. DavisB.R. SimpsonL.M. AldermanM.H. AtlasS.A. BasileJ.N. CuyjetA.B. DartR. FelicettaJ.V. GrimmR.H. HaywoodL.J. JafriS.Z.A. ProschanM.A. ThadaniU. WheltonP.K. WrightJ.T. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.Hypertension200648337438410.1161/01.HYP.0000231662.77359.de16864749
     [Google Scholar]
  5. ZhuJ. ChenN. ZhouM. GuoJ. ZhuC. ZhouJ. MaM. HeL. Calcium channel blockers versus other classes of drugs for hypertension.Cochr. Datab. Syst. Rev.202211CD00365435000192
     [Google Scholar]
  6. LiuH. ZhangX. ZhouY. NguyenT.N. ZhangL. XingP. LiZ. ShenH. ZhangY. HuaW. XuH. ZhuX. ChenL. ZuoQ. ZhaoR. LiQ. DaiD. ZhangY. XuY. HuangQ. LiuJ. YangP. Association between blood pressure and different antihypertensive drugs with outcome after ischemic stroke: A mendelian randomization study.Int. J. Stroke202318101247125410.1177/1747493023118569537337369
     [Google Scholar]
  7. HuttonB. SalantiG. CaldwellD.M. ChaimaniA. SchmidC.H. CameronC. IoannidisJ.P.A. StrausS. ThorlundK. JansenJ.P. MulrowC. Catalá-LópezF. GøtzscheP.C. DickersinK. BoutronI. AltmanD.G. MoherD. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations.Ann. Intern. Med.20151621177778410.7326/M14‑238526030634
     [Google Scholar]
  8. ZhangZ. YangH. GuoH. Comparative efficacy and safety of six angiotensin II receptor blockers in hypertensive patients: A network meta-analysis.Int. J. Clin. Pharm.20244651034104310.1007/s11096‑024‑01755‑538861046
     [Google Scholar]
  9. NerenbergK.A. ZarnkeK.B. LeungA.A. DasguptaK. ButaliaS. McBrienK. HarrisK.C. NakhlaM. CloutierL. GelferM. Lamarre-ClicheM. MilotA. BolliP. TremblayG. McLeanD. PadwalR.S. TranK.C. GroverS. RabkinS.W. MoeG.W. HowlettJ.G. LindsayP. HillM.D. SharmaM. FieldT. WeinT.H. ShoamaneshA. DresserG.K. HametP. HermanR.J. BurgessE. GrynS.E. GrégoireJ.C. LewanczukR. PoirierL. CampbellT.S. FeldmanR.D. LavoieK.L. TsuyukiR.T. HonosG. PrebtaniA.P.H. KlineG. SchiffrinE.L. Don-WauchopeA. TobeS.W. GilbertR.E. LeiterL.A. JonesC. WooV. HegeleR.A. SelbyP. PipeA. McFarlaneP.A. OhP. GuptaM. BaconS.L. KaczorowskiJ. TrudeauL. CampbellN.R.C. HiremathS. RoereckeM. ArcandJ. RuzickaM. PrasadG.V.R. ValléeM. EdwardsC. SivapalanP. PennerS.B. FournierA. BenoitG. FeberJ. DionneJ. MageeL.A. LoganA.G. CôtéA.M. ReyE. FirozT. KuyperL.M. GaborJ.Y. TownsendR.R. RabiD.M. DaskalopoulouS.S. Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children.Can. J. Cardiol.201834550652510.1016/j.cjca.2018.02.02229731013
     [Google Scholar]
  10. MotokiH. KoyamaJ. IzawaA. TomitaT. MiyashitaY. TakahashiM. IkedaU. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy.Echocardiography201431101230123810.1111/echo.1254824645985
     [Google Scholar]
  11. ZhaoZ.G. ChenY.J. Systematic evaluation of amlodipine versus levamlodipine in the treatment of mild to moderate hypertensive disorders.Evalua. Analy. Dru. Us. Chin. Hospi.20151503318321
     [Google Scholar]
  12. LiX. Comparative analysis of adverse reactions due to levamlodipine versus amlodipine, nifedipine, and felodipine.China Medi. Guide20161435115116
     [Google Scholar]
  13. RenX.L. HeZ. HuangL. Meta-analysis of the effectiveness and safety of levamlodipine versus amlodipine in the treatment of essential hypertension.Chin. Pharm.2012231211201124
     [Google Scholar]
  14. LongY.L. GuoQ. LiuG.J. Meta-analysis of the efficacy and safety of levamlodipine versus amlodipine and different doses of levamlodipine in the treatment of hypertension.West China Medi. J.20193404410418
     [Google Scholar]
  15. NittaY. YamamotoR. YamaguchiY. KatsudaS. KakuB. TaguchiT. TakabatakeS. NakahamaK. YamagishiM. Impact of long-acting calcium channel blockers on the prognosis of patients with coronary artery disease with and without chronic kidney disease: A comparison of three drugs.J. Int. Med. Res.201038125326510.1177/14732300100380013020233537
     [Google Scholar]
  16. YangW.Y. MelgarejoJ.D. ThijsL. ZhangZ.Y. BoggiaJ. WeiF.F. HansenT.W. AsayamaK. OhkuboT. JeppesenJ. DolanE. Stolarz-SkrzypekK. MalyutinaS. CasigliaE. LindL. FilipovskýJ. MaestreG.E. LiY. WangJ.G. ImaiY. Kawecka-JaszczK. SandoyaE. NarkiewiczK. O’BrienE. VerhammeP. StaessenJ.A. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes.JAMA2019322540942010.1001/jama.2019.981131386134
     [Google Scholar]
  17. ChaugaiS. SherpaL.Y. SepehryA.A. KermanS.R.J. ArimaH. Effects of long- and intermediate-acting dihydropyridine calcium channel blockers in hypertension: A systematic review and meta-analysis of 18 prospective, randomized, actively controlled trials.J. Cardiovasc. Pharmacol. Ther.201823543344510.1177/107424841877134129739234
     [Google Scholar]
  18. StepaniukN. PiniazhkoO. PoshyvakO. BessarabT. HudzN. GavrilukI. Management of risks of adverse drug reactions according to the ADR report form data from Lviv region healthcare facilities in 2022.Georgian Med. News2023340-341768037805878
     [Google Scholar]
  19. LiangL. KungJ.Y. MitchelmoreB. CaveA. BanhH.L. Comparative peripheral edema for dihydropyridines calcium channel blockers treatment: A systematic review and network meta-analysis.J. Clin. Hypertens. (Greenwich)202224553655410.1111/jch.1443635234349
     [Google Scholar]
  20. HosieJ. BremnerA.D. FellP.J. JamesG.V. SaulP.A. TaylorS.H. Side effects of dihydropyridine therapy: Comparison of amlodipine and nifedipine retard.J. Cardiovasc. Pharmacol.199322Suppl. AS9S127522287
     [Google Scholar]
  21. DougallH.T. McLayJ. A comparative review of the adverse effects of calcium antagonists.Drug Saf.19961529110610.2165/00002018‑199615020‑000028884161
     [Google Scholar]
  22. ZhouL.Y. DengS. XuP. Expert consensus on comprehensive clinical evaluation of oral calcium channel blocker drugs (Hunan).Chin. J. Hospi. Pharm.202343771173710.1097/CCM.000000000000208727749343
     [Google Scholar]
  23. ZhangW.F. Expert consensus on comprehensive clinical evaluation of oral dihydropyridine calcium channel blocker drugs in Jiangxi Province under centralized banded procurement policy.Mod. Appl. Pharm. China2023402333343340
     [Google Scholar]
  24. Expert consensus on the evaluation and selection of dihydropyridine calcium channel blockers in Guangdong Province.Guangd. Pharma. Soc. Pharm. Today20241112
     [Google Scholar]
/content/journals/chyr/10.2174/0115734021357729250214090452
Loading
Efficacy and Safety of Dihydropyridine Calcium Channel Blockers for Primary Hypertension: A Bayesian Network Meta-analysis
Current Hypertension Reviews 21, 117 (2025); https://doi.org/10.2174/0115734021357729250214090452
/content/journals/chyr/10.2174/0115734021357729250214090452
/content/journals/chyr/10.2174/0115734021357729250214090452
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article. Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): calcium channel blockers; diastolic blood pressure; Dihydropyridine; levamlodipine; network meta-analysis; primary hypertension

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test